Richard Daniell is Exec. VP, European Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 0 shares of TEVA, which is worth approximately $0. The most recent transaction as insider was on Mar 03, 2021, when has been sold 2,101 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Richard Daniell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2021
BUY
Exercise of conversion of derivative security
-
2,101 Added 14.04%
12,866 Ordinary Shares
Mar 01 2021
SELL
Open market or private sale
$223,488 $10.85 p/Share
20,598 Reduced 65.68%
10,765 Ordinary Shares
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
20,598 Added 39.64%
31,363 Ordinary Shares
Feb 09 2021
SELL
Open market or private sale
$870,328 $12.72 p/Share
68,422 Reduced 86.41%
10,765 Ordinary Shares
Feb 09 2021
BUY
Grant, award, or other acquisition
-
55,287 Added 41.11%
79,187 Ordinary Shares
Feb 09 2021
BUY
Exercise of conversion of derivative security
-
13,135 Added 35.47%
23,900 Ordinary Shares
RD

Richard Daniell

Exec. VP, European Commercial
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA